# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2050143 | Binding | Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | ALA2046359 | cell-based format | Scientific Literature | |
2. | ALA2050144 | Binding | Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | ALA2046359 | cell-based format | Scientific Literature | |
3. | ALA2050145 | Binding | Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | ALA2046359 | cell-based format | Scientific Literature | |
4. | ALA2050146 | Binding | Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 6 | ALA2046359 | cell-based format | Scientific Literature | |
5. | ALA2050147 | Binding | Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 6 | ALA2046359 | cell-based format | Scientific Literature | |
6. | ALA2050148 | Binding | Ratio of SU4312 IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
7. | ALA2050149 | Functional | Antiproliferative activity against human A431 cells after 48 hrs by CYQUANT assay | Homo sapiens | 13 | ALA2046359 | cell-based format | Scientific Literature | |
8. | ALA2050150 | Functional | Antiangiogenic activity in VEGF/bFGF-stimulated chicken embryo after 48 hrs by CAM assay | Gallus gallus | 14 | ALA2046359 | assay format | Scientific Literature | |
9. | ALA2050151 | Functional | Growth inhibition of human CCRF-CEM cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
10. | ALA2050152 | Functional | Growth inhibition of human HL-60(TB) cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
11. | ALA2050153 | Functional | Growth inhibition of human K562 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
12. | ALA2050154 | Functional | Growth inhibition of human MOLT4 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
13. | ALA2050155 | Functional | Growth inhibition of human RPMI8226 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
14. | ALA2050156 | Functional | Growth inhibition of human SR cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
15. | ALA2050157 | Functional | Growth inhibition of human A549 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
16. | ALA2050158 | Functional | Growth inhibition of human EKVX cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
17. | ALA2050159 | Functional | Growth inhibition of human HOP62 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
18. | ALA2050160 | Functional | Growth inhibition of human HOP92 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
19. | ALA2050161 | Functional | Growth inhibition of human NCI-H226 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature | |
20. | ALA2050162 | Functional | Growth inhibition of human NCI-H23 cells | Homo sapiens | 1 | ALA2046359 | cell-based format | Scientific Literature |